William A. Knight

3.6k total citations · 2 hit papers
68 papers, 2.5k citations indexed

About

William A. Knight is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William A. Knight has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William A. Knight's work include Pancreatitis Pathology and Treatment (8 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (7 papers). William A. Knight is often cited by papers focused on Pancreatitis Pathology and Treatment (8 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (7 papers). William A. Knight collaborates with scholars based in United States, United Kingdom and Australia. William A. Knight's co-authors include William McGuire, C. Kent Osborne, E Gregory, Robert B. Livingston, Michael G. Yochmowitz, Gary C. Chamness, Gary M. Clark, Tamilyn Bakas, Elaine Skalabrin and Pierre Amarenco and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

William A. Knight

61 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

1977 588 citations William A. Knight et al. profile →
The value of estrogen and progesterone receptors in the treatment of breast cancer

1980 579 citations William A. Knight et al. profile →

Peers

William A. Knight

ONCOL

GENET

EPIDE

Fiemu E. Nwariaku United States

John W. Kugler United States

Gianfilippo Bertelli United Kingdom

Ana Barac United States

Shozo Ohsumi Japan

Shih-Jen Hwang United States

Ezzeldin M. Ibrahim Saudi Arabia

Ian Chin‐Yee Canada

H.T. Ford United Kingdom

Fiemu E. Nwariaku United States

William A. Knight

367 ×0.4

ONCOL

175 ×0.2

GENET

299 ×0.4

796 ×1.8

310 ×0.8

EPIDE

Citations per year, relative to William A. Knight William A. Knight (= 1×) peers Fiemu E. Nwariaku

Countries citing papers authored by William A. Knight

Since Specialization

Citations

This map shows the geographic impact of William A. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Knight more than expected).

Fields of papers citing papers by William A. Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Knight. The network helps show where William A. Knight may publish in the future.

Co-authorship network of co-authors of William A. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Knight. A scholar is included among the top collaborators of William A. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Knight. William A. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knight, William A., et al.. (2025). Protoporphyrin IX plasma and blood pharmacokinetics and brain tumor distribution determined by a validated LC–MS/MS method. Scientific Reports. 15(1). 21521–21521. 1 indexed citations

Sanai, Nader, Yoshie Umemura, Jennifer K. Molloy, et al.. (2024). Niraparib efficacy in patients with newly-diagnosed glioblastoma: Clinical readout of a phase 0/2 "trigger" trial.. Journal of Clinical Oncology. 42(16_suppl). 2002–2002. 2 indexed citations

Knight, William A., et al.. (2024). A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients. Journal of Pharmaceutical and Biomedical Analysis. 245. 116150–116150. 3 indexed citations

Mehta, Shwetal, Nader Sanai, Jennifer K. Molloy, et al.. (2023). A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 41(16_suppl). 2069–2069. 3 indexed citations

Mehta, Shwetal, Artak Tovmasyan, An‐Chi Tien, et al.. (2021). EXTH-09. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR LY3295668. Neuro-Oncology. 23(Supplement_6). vi165–vi165. 1 indexed citations

Bonomo, Jordan, William A. Knight, Charles J. Prestigiacomo, et al.. (2020). Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm. Stroke. 51(6). 1902–1909. 24 indexed citations

Stein, Deborah M. & William A. Knight. (2017). Emergency Neurological Life Support: Traumatic Spine Injury. Neurocritical Care. 27(S1). 170–180. 25 indexed citations

Knight, William A., et al.. (2016). Exploring support for shale gas extraction in the United Kingdom. Energy Policy. 98. 582–589. 31 indexed citations

Stein, Deborah M., et al.. (2015). Emergency Neurological Life Support: Traumatic Spine Injury. Neurocritical Care. 23(S2). 155–164. 10 indexed citations

10.

Hart, Kimberly W., et al.. (2014). Electroencephalography findings in patients presenting to the ED for evaluation of seizures. The American Journal of Emergency Medicine. 33(1). 100–103. 2 indexed citations

11.

Adeoye, Opeolu, William A. Knight, Jane Khoury, et al.. (2014). A Matched Comparison of Eptifibatide Plus rt-PA Versus rt-PA Alone in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 23(5). e313–e315. 6 indexed citations

12.

Knight, William A., Kimberly W. Hart, Opeolu Adeoye, et al.. (2013). The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest. Epilepsy Research. 106(3). 396–402. 43 indexed citations

13.

McMullan, Jason T., Jared C. Bentley, Gregory J. Fermann, et al.. (2012). Ground Emergency Medical Services Requests for Helicopter Transfer of ST‐segment Elevation Myocardial Infarction Patients Decrease Medical Contact to Balloon Times in Rural and Suburban Settings. Academic Emergency Medicine. 19(2). 153–160. 22 indexed citations

14.

Palmer, Christopher, et al.. (2011). Helicopter Scene Response for a STEMI Patient Transported Directly to the Cardiac Catheterization Laboratory. Air Medical Journal. 30(6). 289–292. 2 indexed citations

15.

McMullan, Jason T., Jared C. Bentley, Gregory J. Fermann, et al.. (2011). Reperfusion Is Delayed Beyond Guideline Recommendations in Patients Requiring Interhospital Helicopter Transfer for Treatment of ST-segment Elevation Myocardial Infarction. Annals of Emergency Medicine. 57(3). 213–220.e1. 22 indexed citations

16.

Knight, William A., Phyllis J. Goodman, Sarah A. Taylor, et al.. (1990). Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. Investigational New Drugs. 8(S1). S87–S89. 1 indexed citations

17.

Leff, Richard, et al.. (1989). Pituitary abscess after autologous bone marrow transplantation. American Journal of Hematology. 31(1). 62–64. 14 indexed citations

18.

Vance, Ralph, et al.. (1983). Phase II evaluation of MGBG in non-small cell carcinoma of the lung. Investigational New Drugs. 1(1). 89–93. 4 indexed citations

19.

Knight, William A., et al.. (1977). Inherited defect in hereditary pancreatitis. Digestive Diseases and Sciences. 22(11). 999–1004. 15 indexed citations

20.

Knight, William A.. (1973). Neurofibromatosis Associated With Malignant Neurofibromas. Archives of Dermatology. 107(5). 747–747. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact